Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Geriatrics | 4 | 2021 | 74 | 1.290 |
Why?
|
| Dementia | 3 | 2022 | 436 | 0.710 |
Why?
|
| Education, Continuing | 1 | 2021 | 29 | 0.690 |
Why?
|
| Goals | 2 | 2022 | 126 | 0.650 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 222 | 0.550 |
Why?
|
| Multiple Chronic Conditions | 3 | 2024 | 13 | 0.550 |
Why?
|
| Nursing Homes | 2 | 2016 | 88 | 0.520 |
Why?
|
| Patient-Centered Care | 3 | 2025 | 236 | 0.490 |
Why?
|
| Health Priorities | 3 | 2025 | 42 | 0.430 |
Why?
|
| Remote Consultation | 1 | 2014 | 23 | 0.420 |
Why?
|
| Delirium | 2 | 2014 | 66 | 0.420 |
Why?
|
| Patient Care Planning | 1 | 2014 | 124 | 0.400 |
Why?
|
| Perioperative Care | 1 | 2014 | 217 | 0.340 |
Why?
|
| Education, Medical | 1 | 2014 | 293 | 0.310 |
Why?
|
| Referral and Consultation | 1 | 2013 | 564 | 0.300 |
Why?
|
| Hospitals | 1 | 2011 | 435 | 0.280 |
Why?
|
| Biomedical Research | 1 | 2013 | 561 | 0.260 |
Why?
|
| Mental Disorders | 1 | 2014 | 910 | 0.240 |
Why?
|
| Clinical Competence | 1 | 2013 | 1050 | 0.240 |
Why?
|
| Renal Dialysis | 1 | 2012 | 951 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 2 | 2025 | 1295 | 0.220 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 934 | 0.210 |
Why?
|
| Primary Health Care | 3 | 2025 | 775 | 0.210 |
Why?
|
| Pilot Projects | 4 | 2020 | 1445 | 0.200 |
Why?
|
| Aged | 10 | 2025 | 21025 | 0.200 |
Why?
|
| Qualitative Research | 2 | 2025 | 730 | 0.170 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 689 | 0.170 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 6797 | 0.170 |
Why?
|
| Wearable Electronic Devices | 1 | 2022 | 128 | 0.160 |
Why?
|
| Massachusetts | 3 | 2016 | 122 | 0.160 |
Why?
|
| Maine | 2 | 2016 | 11 | 0.140 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 327 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 338 | 0.140 |
Why?
|
| Deprescriptions | 1 | 2017 | 9 | 0.130 |
Why?
|
| Humans | 15 | 2025 | 131163 | 0.130 |
Why?
|
| Ambulatory Care | 1 | 2020 | 401 | 0.130 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2017 | 88 | 0.120 |
Why?
|
| Videoconferencing | 1 | 2016 | 21 | 0.120 |
Why?
|
| Restraint, Physical | 1 | 2016 | 26 | 0.120 |
Why?
|
| Veterans | 2 | 2024 | 1763 | 0.110 |
Why?
|
| Psychomotor Agitation | 1 | 2014 | 58 | 0.110 |
Why?
|
| Long-Term Care | 1 | 2014 | 69 | 0.100 |
Why?
|
| Haloperidol | 1 | 2014 | 22 | 0.100 |
Why?
|
| Morphine | 1 | 2014 | 81 | 0.100 |
Why?
|
| Program Development | 1 | 2014 | 179 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2020 | 844 | 0.090 |
Why?
|
| Antipsychotic Agents | 1 | 2016 | 375 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2014 | 447 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 321 | 0.090 |
Why?
|
| Cholinergic Antagonists | 1 | 2011 | 46 | 0.080 |
Why?
|
| United States | 4 | 2025 | 12072 | 0.080 |
Why?
|
| Benzodiazepines | 1 | 2011 | 107 | 0.080 |
Why?
|
| Analgesics | 1 | 2011 | 120 | 0.080 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 878 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 2011 | 321 | 0.070 |
Why?
|
| Health Personnel | 1 | 2013 | 541 | 0.070 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2024 | 729 | 0.070 |
Why?
|
| Male | 6 | 2025 | 64957 | 0.060 |
Why?
|
| Aging | 1 | 2014 | 1242 | 0.060 |
Why?
|
| Age Factors | 1 | 2012 | 2825 | 0.060 |
Why?
|
| Female | 6 | 2025 | 70963 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 3061 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5196 | 0.050 |
Why?
|
| Polypharmacy | 1 | 2024 | 36 | 0.050 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2025 | 146 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2024 | 294 | 0.050 |
Why?
|
| Patient Preference | 1 | 2025 | 151 | 0.050 |
Why?
|
| Quality of Life | 1 | 2012 | 2082 | 0.050 |
Why?
|
| Middle Aged | 2 | 2025 | 28601 | 0.040 |
Why?
|
| Adult | 1 | 2020 | 31282 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1267 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 824 | 0.030 |
Why?
|
| Nursing Staff | 1 | 2016 | 12 | 0.030 |
Why?
|
| Medical Staff, Hospital | 1 | 2016 | 91 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2014 | 43 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 239 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2014 | 185 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2014 | 184 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 711 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 293 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1618 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 17753 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2701 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 6459 | 0.010 |
Why?
|
| Hospitalization | 1 | 2014 | 1950 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 4886 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 6196 | 0.010 |
Why?
|